source
- Aspen Neuroscience and Bambusa Therapeutics each aim for $135 million IPOsAspen Neuroscience announced plans to raise about $135 million through an initial public offering, proposing to sell roughly 9.38 million shares. Bambusa Therapeutics also filed for an IPO targeti…
- Corxel Group to go public in US by merging with SPAC, targeting oral GLP-1 marketCorxel Group announced that it will become a publicly traded company in the United States through a merger with a special purpose acquisition company. The move follows a similar SPAC transaction by…